美第奇新星生物技术 MNOV 深 沪
等待开盘 11-05 09:30:00 美东时间
1.42
-0.080
-5.33%
华盛通- 最 高1.47
- 今 开1.43
- 成交量 56.09万股
- 最 低 1.42
- 昨 收 1.50
- 总市值 6964.56万
- 52周最高 2.48
- 市盈率 静 --
- 换手率 1.14%
- 52周最低 1.13
- 委 比 -35.36%
- 总股本 4904.62万
- 历史最高 14.50
- 量 比 0.05
- 振 幅 3.33%
- 历史最低 1.12
- 每 手 1
- 风险率 0.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MediciNova Announces Completion of Patient Enrollment in MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
MediciNova, Inc. announced the completion of patient enrollment in its Phase 2 clinical trial (MN-001-NATG-202) evaluating MN-001 (Tipelukast) for treating hypertriglyceridemia and non-alcoholic fatty liver disease (NAFLD) in Type 2 diabetes (T2DM) patients. The trial is a multi-center, randomized, double-blind, placebo-controlled study where patients receive either 500 mg/day of MN-001 or placebo for 24 weeks. Primary endpoints are changes in li...
11-04 12:00
美股大行评级 | 苹果、亚马逊、Cloudflare、西部数据、Twilio等获十多家机构集体上调目标价；杰富瑞首予Cloudflare"持有"评级，目标价250美元
今日重点评级关注：康托·菲茨杰拉德：维持Cabaletta Bio"超配"评级，目标价从15美元升至30美元；HC Wainwright & Co.：维持Invivyd"买入"评级，目标价从5美元升至10美元
11-03 20:20
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Alphatec Holdings (NASDAQ:ATEC) shares rose 21.7% to $19.88 during Fri...
10-31 20:10
D. Boral Capital Maintains Buy on MediciNova, Maintains $9 Price Target
D. Boral Capital analyst Jason Kolbert maintains MediciNova (NASDAQ:MNOV) with a Buy and maintains $9 price target.
10-31 19:45
Why Beneficient (BENF) Shares Soared More Than 46% Overnight?
Beneficient shares surged overnight after the company said it regained compliance with two Nasdaq listing requirements.
10-31 15:52
Why Did MediciNova Stock (MNOV) Jump Over 87% In After-Hours Trading?
MediciNova shares soared over 87% in after-hours trading on Thursday following the publication of promising research.
10-31 11:57
MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication
A new study published in the Journal of Atherosclerosis and Thrombosis highlights that the metabolite MN-002 of tipelukast (MN-001) enhances cholesterol efflux in macrophages by upregulating ABCA1 and ABCG1 proteins, suggesting a novel therapeutic approach for atherosclerosis. MediciNova, Inc. and a Japanese research group conducted the research, which was published in a prestigious journal. MN-001 has shown potential benefits in lipid metabolism...
10-30 23:00
Immunovia AB Strengthens Capital with Directed Share Issue
Immunovia AB ( ($SE:IMMNOV) ) has shared an announcement. Immunovia AB has anno...
10-30 02:04
Immunovia’s PancreaSure Test Validated in Leading Journal
Immunovia AB ( ($SE:IMMNOV) ) has provided an announcement. Immunovia announced...
10-27 21:32
Immunovia’s PancreaSure Test Data to be Highlighted at ACG 2025 Meeting
An update from Immunovia AB ( ($SE:IMMNOV) ) is now available. Immunovia announ...
10-27 15:29
